Frontier Medicines
Frontier Medicines is a clinical-stage biopharmaceutical company pioneering the discovery and development of small-molecule covalent drugs against disease-causing proteins long considered undruggable. Its proprietary Frontier Platform pairs chemoproteomics with artificial intelligence and machine le
Frontier Medicines is an API provider whose private shares are listed on 3 secondary markets: Forge Global, EquityZen, Nasdaq Private Market.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.